ImmuPharma plc (LON:IMM – Get Free Report)’s share price traded up 18.6% on Thursday . The stock traded as high as GBX 4.50 ($0.06) and last traded at GBX 3.98 ($0.05). 6,527,307 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 13,541,125 shares. The stock had previously closed at GBX 3.36 ($0.04).
ImmuPharma Trading Up 18.6 %
The company has a market cap of £16.91 million, a price-to-earnings ratio of -6.88 and a beta of 1.53. The business has a fifty day moving average of GBX 3.72 and a two-hundred day moving average of GBX 2.30.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
